1028 studies found for:    IL13
Show Display Options
RSS Create an RSS feed from your search for:
IL13
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Possible New Therapy for Advanced Cancer
Condition: Adrenocortical Carcinoma
Intervention: Drug: IL-13-PE
2 Completed Sensitivity and Specificity of Nasal Provocation Test in Allergic Rhinitis to House Dust Mites
Condition: Allergic Rhinitis
Intervention: Other: Nasal provocation test
3 Recruiting An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma
Conditions: Brain Neoplasm;   Glioma
Intervention: Drug: IL13-PE38QQR
4 Recruiting Controlled Trial of Chinese Herbal Medicine to Treat Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Drug: Cure-Allergic Rhinitis Syrup;   Drug: Yu-ping-fung San;   Drug: Placebo
5 Completed Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Mixed Oligoastrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: targeted fusion protein therapy;   Procedure: surgery
6 Completed
Has Results
Herbal Treatment for Perennial Allergic Rhinitis
Condition: Perennial Allergic Rhinitis
Interventions: Drug: Shi-Bi-Lin;   Other: Placebo
7 Completed Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Mixed Oligoastrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: targeted fusion protein therapy;   Procedure: surgery
8 Completed Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic Rhinitis
Condition: Allergic Rhinitis
Intervention: Drug: Levocetirizine oral solution
9 Unknown  Effect of Montelukast on Basophils, In-vitro
Conditions: Allergic Asthma;   Allergic Rhinitis
Intervention:
10 Withdrawn Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma
Condition: Recurrent Malignant Glioma
Intervention: Drug: IL13-PE38QQR
11 Completed Study to Investigate Effects of CAL-263 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber
Condition: Allergic Rhinitis
Interventions: Drug: CAL-263;   Drug: Placebo
12 Completed Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Mixed Oligoastrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: targeted fusion protein therapy;   Procedure: surgery
13 Completed Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Mixed Oligoastrocytoma;   Malignant Astrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: targeted fusion protein therapy;   Procedure: surgery
14 Completed Comparison of Effectiveness and Safety of Sublingual Immunotherapy in Children With Allergic Rhinitis
Condition: Allergic Rhinitis
Interventions: Biological: sublingual allergen extract;   Biological: placebo
15 Recruiting A Study Evaluating the Effect of Inhaled and Nasal Corticosteroids on Short Term Growth in Pediatric Subjects With Mild Asthma & Allergic Rhinitis
Conditions: Asthma;   Allergic Rhinitis
Interventions: Drug: Alvesco/Omnaris, QVAR/Beconase, Placebo/Placebo;   Drug: Alvesco/Omnaris, Placebo/Placebo, QVAR/Beconase;   Drug: QVAR/Beconase, Alvesco/Omnaris, Placebo/Placebo;   Drug: QVAR/Beconase, Placebo/Placebo, Alvesco/Omnaris;   Drug: Placebo/Placebo, Alvesco/Omnaris, QVAR/Beconase;   Drug: Placebo/Placebo, QVAR/Beconase, Alvesco/Omnaris
16 Completed IL13-PE38QQR Infusion After Tumor Resection, Followed by Radiation Therapy With or Without Temozolomide in Patients With Newly Diagnosed Malignant Glioma
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Oligoastrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: Surgery for placement;   Procedure: Radiation therapy;   Drug: Temozolomide with radiation therapy
17 Completed The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Interventions: Drug: IL13-PE38QQR;   Procedure: surgery and catheter placement (2 procedures);   Drug: prolifespan 20 with carmustine implant (GLIADEL® Wafer);   Procedure: surgery and wafer placement (1 procedure)
18 Withdrawn Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: cintredekin besudotox;   Procedure: conventional surgery
19 Recruiting Hair Cortisol in Asthma or Allergic Rhinitis Treated With Topical Corticosteroids
Conditions: ASTHMA;   ALLERGIC RHINITIS
Interventions: Drug: Treatment with any inhaled corticosteroid;   Drug: Treatment with any intranasal glucocorticoid
20 Completed A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber
Condition: Seasonal Allergic Rhinitis
Interventions: Drug: QAV680;   Drug: Mometasone Furoate

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years